Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

5-(4-Chloro-phen-yl)-1-methyl-3-oxocyclo-hexa-necarbonitrile.

ABSTRACT: In the title mol-ecule, C(14)H(14)ClNO, the cyclo-hexane ring adopts a chair conformation. The cyano group and the methyl group have axial and equatorial orientations, respectively. The benzene ring has an equatorial orientation. A C-H?? inter-action involving the benzene ring is found in the crystal structure.

SUBMITTER: Mohan RT

PROVIDER: S-EPMC2961578 | biostudies-literature | 2008 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

5-(4-Chloro-phen-yl)-1-methyl-3-oxocyclo-hexa-necarbonitrile.

Mohan R T Sabapathy RT Kamatchi S S Subramanyam M M Thiruvalluvar A A Linden A A

Acta crystallographica. Section E, Structure reports online 20080507 Pt 6

In the title mol-ecule, C(14)H(14)ClNO, the cyclo-hexane ring adopts a chair conformation. The cyano group and the methyl group have axial and equatorial orientations, respectively. The benzene ring has an equatorial orientation. A C-H⋯π inter-action involving the benzene ring is found in the crystal structure. ...[more]

PMID: 21202532

Similar Datasets

N-(4-Chloro-phen-yl)-4-(2-oxocyclo-pent-yl)butyramide.

Project description:In the title compound, C(15)H(18)ClNO(2), the amide group is coplanar with the chloro-phenyl group, making a dihedral angle of 1.71?(12)°. The cyclo-penta-none ring adopts a twist conformation. A weak intra-molecular C-H?O hydrogen bond is observed. Mol-ecules are linked into cyclic centrosymmetric dimers by paired N-H?O hydrogen bonds.

| S-EPMC2968074 | biostudies-literature

2-[2-Chloro-5-(trifluoro-methyl)-phen-yl]hexa-hydro-pyrimidine monohydrate.

Project description:The mol-ecule of the title compound, C(11)H(12)ClF(3)N(2)·H(2)O, is a substituted hexa-hydro-pyrimidine. There are two crystallographically independent mol-ecules (A and B) and two water mol-ecules in the asymmetric unit of the title compound. Inter-molecular C-H?Cl (× 2), C-H?F, and C-H?N (× 2) hydrogen bonds generate S(5) ring motifs. The dihedral angle between the two benzene rings is 8.17?(11)°. The F atoms in mol-ecule B are disordered over four positions with refined site-occupancies of ca 0.35/0.19/0.29/0.17 for the four components. In the crystal structure, mol-ecules are arranged into one-dimensional extended chains along the c axis and are further stacked along the a axis by directed four-membered O-H?O-H inter-actions, forming two-dimensional networks parallel to the ac plane. The short distances between the centroids of the benzene rings (3.8002-3.8327?Å) indicate the existence of ?-? inter-actions. In addition, the crystal structure is further stabilized by N-H?O, O-H?N (× 4), N-H?Cl and C-H?O (× 2) hydrogen-bonding inter-actions.

| S-EPMC2960557 | biostudies-literature

8-(2-Chloro-phen-yl)-1-(4-chloro-phen-yl)-4-[(E)-(2-chloro-phen-yl)methyl-idene]-6-methyl-4,5,6,7,7a,8-hexa-hydro-1,2,4-oxadiazolo[5,4-d]pyrido[3,4-c][1,5]benzothia-zepine.

Project description:In the title compound, C(33)H(26)Cl(3)N(3)OS, the oxadiazole, piperidine and benzothia-pezine rings adopt envelope, chair and twist-boat conformations, respectively. In the crystal, the mol-ecular aggregation is characterized by chains of centrosymmetrically related pairs connected through Cl?Cl inter-actions [3.533?(2)?Å], extending parallel to (202).

| S-EPMC2979104 | biostudies-literature

2-Amino-6-[(2,6-dichloro-phen-yl)imino]-3-oxocyclo-hexa-1,4-dienecarbaldehyde.

Project description:The title compound, C(13)H(8)Cl(2)N(2)O(2), was obtained by the oxidation of diclofenac {systematic name: 2-[2-(2,6-dichloro-phenyl-amino)-phen-yl]acetic acid}, an anti-inflammatory drug, with hydrogen peroxide catalysed by chlorido[5,10,15,20-tetra-kis-(2,6-dichloro-phen-yl)porphyrinato]manganese(III), using ammonium acetate as co-catalyst. The asymmetric unit contains two crystallographically independent mol-ecules of the title compound (Z' = 2). The close packing of individual mol-ecules is mediated by a series of strong and rather directional N-H?Cl and N-H?O hydrogen bonds, plus weak ?-? [distance between the individual double bonds of symmetry-related imino-quinone rings = 3.7604?(13)?Å] and Cl?O inter-actions [3.0287?(18)?Å].

| S-EPMC3247420 | biostudies-literature

4-(4-Chloro-phen-yl)-8-methyl-2-oxo-1,2,5,6,7,8-hexa-hydro-quinoline-3-carbonitrile.

Project description:The six-membered N-heterocyclic ring of the title compound, C(17)H(15)ClN(2)O, is fused with a methyl-substituted cyclo-hexene ring. The approximately planar nitro-gen-bearing ring (r.m.s. deviation 0.019?Å) is aromatic, and the N atom shows a trigonal-planar coordination; its benzene substituent is aligned at 77.1?(1) °. The cyclo-hexene ring adopts a half-chair conformation. In the crystal, inversion-related mol-ecules are linked by pairs of N-H?O hydrogen bonds, generating dimers.

| S-EPMC3201532 | biostudies-literature

10-(4-Chloro-phen-yl)-9-(4-fluoro-phen-yl)-3,3,6,6-tetra-methyl-3,4,6,7,9,10-hexa-hydro-acridine-1,8(2H,5H)-dione.

Project description:The title compound, C(29)H(29)ClFNO(2), was synthesized by the reaction of 4-fluoro-benzaldehyde, 5,5-dimethyl-cyclo-hexane-1,3-dione and 3-(4-chloro-phenyl-amino)-5,5-dimethyl-cyclo-hex-2-enone in an ionic liquid (1-butyl-3-methyl-imidazolium bromide). X-ray analysis reveals that the 1,4-dihydro-pyridine ring adopts a boat conformation, while each of the attached partially saturated six-membered rings adopts a half-chair conformation. The structure is stabilized by weak C-H?O and C-H?F hydrogen bonds. The mol-ecule has approximate mirror symmetry; the largest deviation from this symmetry concerns the fluoro- and chloro-phenyl rings.

| S-EPMC2960627 | biostudies-literature

2-(4-Chloro-phen-yl)-6-methyl-4-(3-methyl-phen-yl)quinoline.

Project description:In the title compound, C(23)H(18)ClN, the dihedral angles between the quinoline unit and the chloro-benzene and methyl-benzene rings are 2.57?(9) and 56.06?(9)°, respectively. The crystal structure is stabilized by ?-? inter-actions [minimum ring centroid separation = 3.733?(2)?Å].

| S-EPMC3515327 | biostudies-literature

1-[5-(3-Chloro-phen-yl)-2-methyl-3-thi-en-yl]-3,3,4,4,5,5-hexa-fluoro-2-(2-methoxy-phen-yl)-cyclo-pent-1-ene.

Project description:The title compound, C(23)H(15)ClF(6)OS, has thienyl and phenyl-ene substituents on the double-bond C atoms of the envelope-shaped cyclo-pentenyl ring. The aromatic systems are aligned at 55.3 (4) (thien-yl) and 60.8 (7)° (phenyl-ene) with respect to the planar C-C=C-C portion of the main central cyclo-pentenyl ring.

| S-EPMC2977783 | biostudies-literature

N-(2-Chloro-phen-yl)-N'-(2-methyl-phen-yl)succinamide.

Project description:In the title compound, C(17)H(17)ClN(2)O(2), the asymmetric unit contains half a mol-ecule with a centre of symmetry at the mid-point of the central C-C bond. The conformations of the amide O atoms are anti to the methyl-ene atoms. Further, the N-H bonds in the amide fragments are anti to the ortho-chloro/methyl groups in the adjacent benzene rings. The dihedral angle between the benzene ring and the NH-C(O)-CH(2) segment in the two halves of the mol-ecule is 62.0?(2)°. In the crystal, a series of N-H?O inter-molecular hydrogen bonds link the mol-ecules into column-like infinite chains along the a axis. The methyl and Cl groups are disordered with respect to the ortho positions of the benzene ring, with site-occupation factors of 0.5 each.

| S-EPMC3201445 | biostudies-literature

N-(3-Chloro-phen-yl)-N'-(3-methyl-phen-yl)succinamide.

Project description:The asymmetric unit of the title compound, C(17)H(17)ClN(2)O(2), contains one half-mol-ecule with a center of inversion at the mid-point of the central C-C bond. The amide N-H group is anti to the meta-chloro/methyl groups in the adjacent benzene rings. The dihedral angle between the benzene ring and the NH-C(O)-CH(2) segment is 43.5?(1)°. In the crystal, inter-molecular N-H?O hydrogen bonds link the mol-ecules into chains along the a axis. The methyl group and the Cl atom occupy the same position and were treated in a disorder model with site-occupation factors of 0.5 each.

| S-EPMC3213520 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data